860871P

Avanti

C24:1 Mono-sulfo galactosyl (alpha) ceramide (d18:1/24:1)

3-O-Sulfo-D-galactosyl-α1,1′-N-Nervonoyl-D-erythro-sphingsoine (ammonium salt), (synthetic), powder

Empirical Formula (Hill Notation):
C48H94N2O11S
CAS号:
分子量:
907.33
NACRES:
NA.25
价格与库存信息目前不能提供

form

powder

packaging

pkg of 1 × 1 mg (860871P-1mg)

mfr. no.

Avanti Polar Lipids, 860871P

shipped in

dry ice

storage temp.

−20°C

SMILES string

HC@(/C=C/CCCCCCCCCCCCC)(O)C@@(H)(NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)COC@@H(O1)C@H(O)C@@H(OS(O-)(=O)=O)C@H(C@H1CO)O.NH4+

General description

C24:1 Mono-sulfo galactosyl (a) ceramide (d18:1/24:1), also known as 3-O-Sulfo-D-galactosyl-a 1,1′-N-Nervonoyl-D-erythro-sphingsoine, is a synthetic sulfatide that belongs to the class of glycosphingolipids.

Biochem/physiol Actions

Sulfatides play a crucial role in various cellular processes such as protein trafficking, signal transduction and neuronal cell differentiation. Accumulation of 3-O-Sulfogalactosylceramides (sulfatides), due to the deficiency of arylsulfatase A, leads to genetic disease metachromatic leukodystrophy.

Packaging

5 mL Amber Glass Screw Cap Vial (860871P-1mg)

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Flash Point(F)

No data available

Flash Point(C)

No data available

Yanli Cui et al.
Glycoconjugate journal, 25(2), 147-155 (2007-08-19)
3-O-Sulfogalactosylceramides (sulfatides) accumulate in the genetic disease metachromatic leukodystrophy which is due to a defect in the catabolic enzyme, arylsulfatase A. Clinical diagnosis is usually confirmed by in vitro enzymatic deficiency of arylsulfatase A activity. The diagnosis may be complicated...
Analysis of complex lipidomes
Uphoff A, et al.
Medical Applications of Mass Spectrometry (2008)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。